Oral anticoagulants for atrial fibrillation: Which one to choose?
Pace University-Lenox Hill Hospital, New York, NY, USA.
Jennifer Hofmann
JH
Ribowsky
Alison Giordano
AG
Ismael
D000284:Administration, Oral; D000925:Anticoagulants / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001562:Benzimidazoles / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D000069604:Dabigatran; D016527:Drug Costs; D057915:Drug Substitution; D006801:Humans; D009025:Morpholines / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D011725:Pyridines / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D000069552:Rivaroxaban; D020521:Stroke / Q000517:prevention & control*; D013876:Thiophenes / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D014859:Warfarin
D000925:Anticoagulants; D001562:Benzimidazoles; D009025:Morpholines; D011725:Pyridines; D013876:Thiophenes; D014859:Warfarin; D000069552:Rivaroxaban; D000069604:Dabigatran